The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of individualized doses
(50 to 200 milligrams) of topiramate tablets compared against placebo for the prevention of
chronic migraine headaches over a period of 16 weeks.